BMRN — BIOMARIN PHARMACEUTICAL INC
As of Q2 2026, 40 SEC-registered investment managers reported holding BMRN (BIOMARIN PHARMACEUTICAL INC) in their latest 13F filings, with a combined reported value of $3.75B across 112.15M shares. That is -31.3% by share count (-51.08M shares) versus the previous quarter, while reported value moved +11.5%. Ownership is concentrated: the five largest holders account for 62.8% of reported value and the top ten for 82.2%.
Compared with the prior quarter, 2 opened new positions, 18 added to existing stakes, 17 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
BMRN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 18.13M | $1.08B | 0.02% | Reduce |
| Dodge & Cox history | Q2 2026 | 14.84M | $849.43M | 0.45% | Add |
| Norges Bank Investment Management history | Q2 2026 | 8.21M | $469.66M | 0.05% | Add |
| Viking Global Investors history | Q2 2026 | 7.62M | $435.82M | 1.26% | Add |
| AQR Capital Management history | Q2 2026 | 5.70M | $322.54M | 0.11% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 4.82M | $275.97M | 0.01% | Add |
| Elliott Investment Management history | Q1 2025 | 3.50M | $247.44M | 1.64% | Hold |
| Geode Capital Management history | Q2 2026 | 3.91M | $223.89M | 0.01% | Add |
| Capital Research Global Investors history | Q2 2026 | 3.50M | $200.52M | 0.03% | Hold |
| Millennium Management history | Q2 2026 | 2.11M | $120.95M | 0.05% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 1.62M | $92.47M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 1.56M | $89.15M | 0.01% | Reduce |
| Citadel Advisors history | Q2 2026 | 1.40M | $80.28M | 0.01% | Reduce |
| Point72 Asset Management history | Q1 2026 | 1.30M | $73.39M | 0.10% | Add |
| CDPQ (Caisse de Depot) history | Q2 2026 | 1.24M | $70.75M | 0.10% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.20M | $68.78M | 0.01% | Add |
| BNY Mellon history | Q2 2026 | 1.16M | $66.11M | 0.01% | Add |
| Balyasny Asset Management history | Q2 2026 | 1.05M | $60.34M | 0.08% | Reduce |
| Franklin Resources history | Q2 2026 | 936.04K | $53.56M | 0.01% | Hold |
| Arrowstreet Capital history | Q4 2025 | 849.74K | $50.50M | 0.03% | Add |
New Positions (Q2 2026)
- JPMorgan Chase & Co 22.48M sh · $21.84M
- Marshall Wace 97.30K sh · $5.57M
Fully Exited (vs previous quarter)
- Point72 Asset Management sold 1.30M sh · $73.39M
- Janus Henderson Group sold 1.60M sh · $1.54M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dodge & Cox | 14.82M | 14.83M | 15.03M | 15.01M | 14.77M | 14.38M | 14.33M | 14.29M | 14.15M | 13.99M | 13.99M | 13.93M | 13.90M | 14.75M | 14.96M | 15.11M | 14.69M | 14.57M | 14.56M | 14.84M |
| Norges Bank Investment Management | — | — | — | — | — | 2.75M | — | — | — | 3.36M | — | 3.62M | — | 3.57M | — | 2.04M | — | 7.53M | — | 8.21M |
| Viking Global Investors | — | 2.87M | 3.75M | 5.05M | 5.10M | 5.27M | 2.17M | 4.16M | 4.22M | 4.89M | 6.42M | 7.06M | 9.75M | 10.51M | 10.80M | 12.29M | 8.32M | 6.04M | 7.06M | 7.62M |
| AQR Capital Management | 3.35K | 2.30K | 6.11K | 8.05K | 29.09K | 50.20K | 75.70K | 175.39K | 89.06K | 57.07K | 22.66K | 55.37K | 598.50K | 1.28M | 2.93M | 5.58M | 5.93M | 6.69M | 7.68M | 5.70M |
| Fidelity Management & Research (FMR) | 70.62K | 181.22K | 265.45K | 514.28K | 684.01K | 465.27K | 551.65K | 547.58K | 713.80K | 1.07M | 486.48K | 169.66K | 206.54K | 238.16K | 541.51K | 546.10K | 392.81K | 1.84M | 3.57M | 4.82M |
| Geode Capital Management | 2.32M | 2.40M | 2.45M | 2.47M | 2.51M | 2.58M | 2.66M | 2.71M | 2.76M | 2.87M | 2.99M | 3.20M | 3.26M | 3.29M | 3.43M | 3.47M | 3.54M | 3.67M | 3.82M | 3.91M |
| Capital Research Global Investors | 17.65M | 12.67M | 9.39M | 4.94M | 4.94M | 5.65M | 7.21M | 6.76M | 6.02M | 10.77M | 6.52M | 9.69M | 10.49M | 12.99M | 9.15M | 391.88K | 2.54M | 2.55M | 3.49M | 3.50M |
| Millennium Management | 868.49K | 708.04K | 1.30M | 1.53M | 1.88M | 785.45K | 530.22K | 350.41K | 351.65K | 25.27M | 26.50M | 44.00M | 803.38K | 456.96K | 781.97K | 2.85M | 25.00M | 17.50M | 7.50M | 2.11M |
| Charles Schwab Investment Management | 1.05M | 1.10M | 1.13M | 1.20M | 1.22M | 1.24M | 1.26M | 1.27M | 1.30M | 1.38M | 1.34M | 1.35M | 1.40M | 1.42M | 1.53M | 1.56M | 1.40M | 1.42M | 1.59M | 1.62M |
| Northern Trust Corp | 1.36M | 1.36M | 1.33M | 1.30M | 1.29M | 1.31M | 1.31M | 1.18M | 1.22M | 1.15M | 1.08M | 1.58M | 1.48M | 1.73M | 1.70M | 1.66M | 1.66M | 1.55M | 1.59M | 1.56M |
| Citadel Advisors | 588.17K | 1.63M | 2.29M | 1.52M | 1.36M | 354.80K | 443.37K | 784.24K | 528.73K | 4.00M | 2.00M | 1.08M | 1.60M | 774.21K | 1.94M | 623.42K | 706.85K | 1.68M | 4.70M | 1.40M |
| CDPQ (Caisse de Depot) | 6.43K | 3.33K | 31.73K | 24.00K | 39.78K | — | 52.38K | 57.51K | 44.71K | 67.45K | 39.33K | 2.68K | — | — | 56.87K | 637.27K | 913.16K | 1.05M | 945.60K | 1.24M |
| Goldman Sachs Group | 1.57M | 903.07K | 708.62K | 855.40K | 842.83K | 1.17M | 1.13M | 1.43M | 979.60K | 963.08K | 693.22K | 559.80K | 449.97K | 509.45K | 1.59M | 2.11M | 2.29M | 454.91K | 379.60K | 1.20M |
| BNY Mellon | 1.20M | 1.15M | 1.19M | 1.65M | 1.45M | 550.00K | 2.38M | 2.39M | 2.60M | 2.86M | 2.94M | 2.64M | 2.62M | 2.70M | 1.68M | 1.67M | 1.87M | 1.78M | 1.14M | 1.16M |
| Balyasny Asset Management | — | — | 18.85K | 564.70K | 785.79K | 207.60K | 306.12K | 116.53K | 910.40K | 524.57K | 236.94K | 1.05M | 960.62K | 337.10K | 7.75K | 440.70K | 252.82K | 9.10K | 1.36M | 1.05M |
| Franklin Resources | 483.73K | 527.25K | 441.90K | 443.19K | 445.73K | 332.13K | 685.29K | 836.23K | 566.24K | 301.76K | 5.11M | 5.01M | 8.80M | 9.02M | 9.02M | 8.42M | 5.71M | 95.10K | 933.88K | 936.04K |
| Legal & General Investment Management America | 1.10M | 1.08M | 1.18M | 1.25M | 1.23M | 1.17M | 1.17M | 1.22M | 1.22M | 1.39M | 1.38M | 1.52M | 1.47M | 860.93K | 927.68K | 1.06M | 909.58K | 603.58K | 575.19K | 537.47K |
| Invesco Ltd | 425.00K | 425.00K | 425.00K | 425.00K | 425.00K | 425.00K | 425.00K | 9.58M | 9.58M | 8.80M | 6.30M | 6.31M | 6.30M | 504.78K | 501.22K | 618.84K | 544.40K | 457.60K | 419.41K | 494.60K |
| Renaissance Technologies | 381.47K | 651.06K | 491.17K | 734.76K | 744.47K | 630.27K | 781.07K | 732.64K | 581.77K | 386.67K | 542.07K | 116.20K | 418.87K | 435.87K | 895.77K | 1.81M | 1.89M | 1.32M | 1.02M | 451.87K |
| Principal Global Investors | 55.27K | 38.77K | 43.28K | 44.48K | 57.85K | 33.83K | 34.73K | 31.41K | 32.60K | 29.71K | 33.16K | 649.46K | 458.04K | 453.94K | 455.49K | 452.38K | 438.74K | 413.06K | 428.61K | 438.82K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details